AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
2.500
+0.100 (4.17%)
At close: Jun 22, 2026, 4:00 PM EDT
2.530
+0.030 (1.20%)
After-hours: Jun 22, 2026, 7:09 PM EDT
AC Immune Market Cap
AC Immune has a market cap or net worth of $248 million as of June 22, 2026. Its market cap has increased by 47.88% in one year.
Market Cap
248.00M
Enterprise Value
160.12M
1-Year Change
47.88%
Ranking
Category
Stock Price
$2.50
Market Cap Chart
Since September 23, 2016, AC Immune's market cap has decreased from $867.50M to $248.00M, a decrease of -71.41%. That is a compound annual growth rate of -12.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 244.20M | -22.92% |
| Dec 31, 2025 | 316.80M | 17.51% |
| Dec 31, 2024 | 269.60M | -36.36% |
| Dec 29, 2023 | 423.60M | 145.85% |
| Dec 30, 2022 | 172.30M | -52.25% |
| Dec 31, 2021 | 360.80M | -2.88% |
| Dec 31, 2020 | 371.50M | -35.46% |
| Dec 31, 2019 | 575.60M | 6.20% |
| Dec 31, 2018 | 542.00M | -25.42% |
| Dec 29, 2017 | 726.70M | 1.07% |
| Dec 30, 2016 | 719.00M | -17.12% |
| Sep 23, 2016 | 867.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fulcrum Therapeutics | 246.54M |
| Foghorn Therapeutics | 243.66M |
| Fate Therapeutics | 243.61M |
| Sol-Gel Technologies | 243.41M |
| Orchestra BioMed Holdings | 238.92M |
| Whitehawk Therapeutics | 237.72M |
| Canton Strategic Holdings | 233.85M |
| Cybin | 233.67M |